Company Filing History:
3 out of 4 
1 out of 15 
1 out of 2 Years Active: 2022-2024
Title: Innovations and Contributions of Zaifang Ren
Introduction
Zaifang Ren is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate receptor activities. With a total of 5 patents to his name, Ren's work has the potential to impact various therapeutic areas.
Latest Patents
Ren's latest patents include innovative compounds that serve as GLP-1 receptor agonists. The first patent relates to a compound of Formula (I) or its pharmaceutically acceptable derivatives, which modulates the activity of the GLP-1 receptor. This invention also encompasses a pharmaceutical composition and a method for treating or preventing diseases associated with GLP-1 receptor activity. Another notable patent involves SSAO inhibitors, which also pertain to a compound of Formula (I′) or (I) that modulates SSAO activity. This patent includes a pharmaceutical composition and a method for treating diseases where SSAO plays a critical role.
Career Highlights
Throughout his career, Zaifang Ren has worked with notable companies such as Eccogene (Shanghai) Co., Ltd. and Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of new therapeutic solutions.
Collaborations
Ren has collaborated with several professionals in his field, including Xuefeng Sun and Qing Xu. These collaborations have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.
Conclusion
Zaifang Ren's contributions to pharmaceutical innovations through his patents demonstrate his commitment to advancing medical science. His work in developing GLP-1 receptor agonists and SSAO inhibitors showcases the potential for new treatments in various diseases.